Ad
related to: older generation mechanical aortic valve anticoagulation device pdfwexnermedical.osu.edu has been visited by 10K+ users in the past month
- Prepare For Your Visit
What to bring to your visit
plus heart & vascular resources
- Find a Doctor
Meet with our experts to diagnose
your symptoms and receive treatment
- Patient Testimonials
Hear from our patients
about their Ohio State experience
- Should I See A Heart Doc
Talk to your doc about your heart
and learn what to ask
- Prepare For Your Visit
Search results
Results from the WOW.Com Content Network
Aortic regurgitation, on the other hand, has many causes: degeneration of the cusps, endocarditis, bicuspid aortic valve, aortic root dilatation, trauma, connective tissue disorders such as Marfan syndrome or Ehlers-Danlos lead to imperfect closure of the valve during diastole, hence the blood is returning from the aorta towards the left ...
The implantation of the Hancock Aortic Tissue Valve typically involves open-heart surgery. [14] During the procedure, the damaged or diseased native aortic valve is removed, and the prosthetic valve is sutured in its place. The secure attachment of the valve is crucial to ensure proper functionality and prevent complications such as leakage.
An aortic homograft is an aortic valve from a human donor, retrieved either after their death or from a heart that is removed to be replaced during a heart transplant. [12] A pulmonary autograft, also known as the Ross procedure , is where the aortic valve is removed and replaced with the patient's own pulmonary valve (the valve between the ...
Valve sparing aortic root replacement (VSARR) is an alternative procedure to the composite aortic valve graft (CAGVR, Bentall procedure). A notable benefit of VSARR is the reduced need for anticoagulation, as the patient's own aortic valve is spared and does not need to be replaced with a mechanical or bioprosthetic valve. [11]
[31] [32] It was the first aortic valve device to receive FDA approval, in November 2011 for use in inoperable patients and in October 2012 for use in patients at high surgical risk. [33] The device is effective in improving functioning in patients with severe aortic stenosis.
The choice of valve depends upon the patient's age, medical condition, preferences, and lifestyle. [13] Typically, patients younger than 65 years old will receive a mechanical valve unless they are unable to take long-term anticoagulation, and patients older than 70 years will receive a bioprosthetic valve. [10]
Catheter replacement of the aortic valve (called trans-aortic valve replacement or implementation [TAVR or TAVI]) is a minimally invasive option for those suffering from aortic valve stenosis. TAVR is commonly performed by guiding a catheter from the groin to the narrowed valve via the aorta using realtime x-ray technology.
Contrary to valve replacement with mechanical prostheses inhibition of the blood clotting system (anticoagulation) is not necessary after aortic valve repair. Blood-thinning may only be necessary if atrial fibrillation occurs or persists in order to prevent blood clot formation in the left atrium.
Ad
related to: older generation mechanical aortic valve anticoagulation device pdfwexnermedical.osu.edu has been visited by 10K+ users in the past month